呼吸指南

订阅

MedSci主页 / 所有栏目 / 呼吸指南

慢性阻塞性肺疾病中医肺康复临床应用指南

2021-11-06 中华中医药学会内科分会肺系病专业委员会 中医杂志

慢性阻塞性肺疾病慢性阻塞性肺疾病与肺心病

本指南适用于各级中医院、综合医院或社区医疗服务中心、康复中心等医疗机构的慢阻肺中医肺康复治疗。

中文标题：

慢性阻塞性肺疾病中医肺康复临床应用指南

发布机构：

中华中医药学会内科分会肺系病专业委员会

发布日期：

2021-11-06

简要介绍：

本指南适用于各级中医院、综合医院或社区医疗服务中心、康复中心等医疗机构的慢阻肺中医肺康复治疗。本指南的主要目标人群是呼吸内科、康复科和全科医师的医务人员，根据医疗资源和康复措施的可及性，对慢阻肺患者合理使用中医肺康复技术。

相关资料下载：
[AttachmentFileName(sort=1, fileName=慢性阻塞性肺疾病中医肺康复临床应用指南.pdf)] GetToolGuiderByIdResponse(projectId=1, id=7dfaf1c00226e967, title=慢性阻塞性肺疾病中医肺康复临床应用指南, enTitle=, guiderFrom=中医杂志, authorId=0, author=, summary=本指南适用于各级中医院、综合医院或社区医疗服务中心、康复中心等医疗机构的慢阻肺中医肺康复治疗。, cover=https://img.medsci.cn/20211120/1637337728053_5579292.jpg, journalId=0, articlesId=null, associationId=679, associationName=中华中医药学会内科分会肺系病专业委员会, associationIntro=中华中医药学会肺系病分会是由卫生部中日友好医院张洪春教授、晁恩祥教授，天津中医药大学第二附属医院孙增涛教授，青岛海慈医疗集团周兆山教授，北京中医药大学附属东直门医院王成祥教授，安徽中医学院李泽庚教授，河南中医学院第一附属医院李素云教授，广东省中医院林琳教授等一批专门从事中医药防治肺系病临床、科研、教学工作的学术骨干发起，经中华中医药学会常务理事会批准成立的学术组织。 中华中医药学会肺系病分会的前身是中华中医药学会内科分会肺系病学组（后为专业委员会）。内科分会肺系病学组（后为专业委员会）是1981年中华中医药学会内科分会成立后组建的第一批三级学术组织。在内科分会领导指导下，内科分会肺系病学组（后为专业委员会）于1982年在昆明成立，并举办了第一届全国中医内科肺系病学术交流大会。近30年来，在中华中医药学会、内科分会有关领导的关心与指导下，内科分会肺系病学组（后为专业委员会）晁恩祥教授（卫生部中日友好医院）、杨明均教授（成都中医药大学附属医院）、洪广祥教授（江西中医学院）、张贻芳教授（中国中医科学院西苑医院）、武维屏教授（北京中医药大学附属东直门医院）等老一辈专门从事中医防治肺系病临床、科研、教学的有志之士，组织、带领全国有关人士开展了一系列学术交流和科研协作工作。先后在江西南昌、吉林长春、海南海口、山东邹城、山东威海、广西柳州、新疆乌鲁木齐、贵州贵阳、青海西宁、江西宜春、内蒙古海拉尔等城市召开了14次全国中医内科肺系病学术交流大会，有力促进了中医药防治呼吸系统疾病学术的交流、医疗水平的提高，培养了一大批从事中医内科肺系病防治工作的骨干。 同时，内科分会肺系病学组（后为专业委员会）积极组织中医内科学专著、中医呼吸病学专著、名老中医经验传承专著等一系列中医著作的编辑与出版工作，相继出版了《临床中医内科学》、《今日中医内科》、《中医急症医学》等有较高影响力中医著作，推动了内科肺系病学术经验的整理与提高。 内科分会肺系病学组（后为专业委员会）积极组织专家参与中医药防控呼吸道传染病临床救治工作，参与国家诊疗方案制定等，在临床上显示了其优势与特色，得到了国家领导同志的肯定，得到了广大患者的欢迎。如在传染病&ldquo;非典&rdquo;、&ldquo;人禽流感&rdquo;、&ldquo;甲型流感&rdquo;的防治工作中，不仅中医药的临床疗效得到了国际社会的认同，同时也涌现出一大批以晁恩祥、林琳等同志为代表的模范人物，为中医药界争得了荣誉。中医药在肺系病缓解期上、疑难杂证的治疗上均取得较大进展，目前，由国家十一五支撑计划、国家重大传染病专项等资助的多项肺系病科研项目，包括慢阻肺、哮喘、肺痿等的中医药疗效研究正在全国肺系病骨干单位中开展，有力促进中医药呼吸专业人才之间合作交流的同时，也促进了中医药科研工作的发展和诊疗水平的提高。 中华中医药学会呼吸病分会的成立，必将对中医药防治肺系病的学术交流搭建更大的平台，扩大中医药对热病、传染性疾病、呼吸系统疑难疾病诊疗经验的推广与影响，进一步促进中医药防治肺系病国际合作，有利于中青年优秀人才的培养。, copyright=0, guiderPublishedTime=Sat Nov 06 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">本指南适用于各级中医院、综合医院或社区医疗服务中心、康复中心等医疗机构的慢阻肺中医肺康复治疗。本指南的主要目标人群是呼吸内科、康复科和全科医师的医务人员，根据医疗资源和康复措施的可及性，对慢阻肺患者合理使用中医肺康复技术。</span></p>, tagList=[TagDto(tagId=2115, tagName=慢性阻塞性肺疾病), TagDto(tagId=117733, tagName=慢性阻塞性肺疾病与肺心病)], categoryList=[CategoryDto(categoryId=12, categoryName=呼吸, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=2115, guiderKeyword=慢性阻塞性肺疾病, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=2, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3262, appHits=349, showAppHits=0, pcHits=1199, showPcHits=2912, likes=7, shares=55, comments=16, approvalStatus=1, publishedTime=Sat Nov 20 00:06:41 CST 2021, publishedTimeString=2021-11-06, pcVisible=1, appVisible=1, editorId=1614372, editor=MedSciZeng, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=FUNNYMAN, createdTime=Sat Nov 20 00:06:29 CST 2021, updatedBy=1614372, updatedName=MedSciZeng, updatedTime=Sat Jan 06 16:15:15 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=慢性阻塞性肺疾病中医肺康复临床应用指南.pdf)])
慢性阻塞性肺疾病中医肺康复临床应用指南.pdf
下载请点击：
评论区 (12)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1214557, encodeId=f516121455e75, content=***, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20ba8123961, createdName=ms9000001712287726, createdTime=Tue Apr 26 15:04:19 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210079, encodeId=e81b12100e9cc, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c66e8108716, createdName=ms5000000188518580, createdTime=Sun Apr 10 18:10:13 CST 2022, time=2022-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183213, encodeId=51d811832135f, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=09a95430606, createdName=花儿吃了那女孩, createdTime=Tue Jan 11 14:41:47 CST 2022, time=2022-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082949, encodeId=5ee71082949c5, content=。。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de6e5721166, createdName=滚蛋吧的肿瘤君, createdTime=Wed Dec 22 08:27:56 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077617, encodeId=ce0110e761775, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de6e5721166, createdName=滚蛋吧的肿瘤君, createdTime=Tue Dec 07 08:03:51 CST 2021, time=2021-12-07, status=1, ipAttribution=)]
    2022-04-26 ms9000001712287726

    ***

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1214557, encodeId=f516121455e75, content=***, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20ba8123961, createdName=ms9000001712287726, createdTime=Tue Apr 26 15:04:19 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210079, encodeId=e81b12100e9cc, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c66e8108716, createdName=ms5000000188518580, createdTime=Sun Apr 10 18:10:13 CST 2022, time=2022-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183213, encodeId=51d811832135f, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=09a95430606, createdName=花儿吃了那女孩, createdTime=Tue Jan 11 14:41:47 CST 2022, time=2022-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082949, encodeId=5ee71082949c5, content=。。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de6e5721166, createdName=滚蛋吧的肿瘤君, createdTime=Wed Dec 22 08:27:56 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077617, encodeId=ce0110e761775, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de6e5721166, createdName=滚蛋吧的肿瘤君, createdTime=Tue Dec 07 08:03:51 CST 2021, time=2021-12-07, status=1, ipAttribution=)]
    2022-04-10 ms5000000188518580

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1214557, encodeId=f516121455e75, content=***, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20ba8123961, createdName=ms9000001712287726, createdTime=Tue Apr 26 15:04:19 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210079, encodeId=e81b12100e9cc, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c66e8108716, createdName=ms5000000188518580, createdTime=Sun Apr 10 18:10:13 CST 2022, time=2022-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183213, encodeId=51d811832135f, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=09a95430606, createdName=花儿吃了那女孩, createdTime=Tue Jan 11 14:41:47 CST 2022, time=2022-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082949, encodeId=5ee71082949c5, content=。。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de6e5721166, createdName=滚蛋吧的肿瘤君, createdTime=Wed Dec 22 08:27:56 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077617, encodeId=ce0110e761775, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de6e5721166, createdName=滚蛋吧的肿瘤君, createdTime=Tue Dec 07 08:03:51 CST 2021, time=2021-12-07, status=1, ipAttribution=)]
    2022-01-11 花儿吃了那女孩

    学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1214557, encodeId=f516121455e75, content=***, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20ba8123961, createdName=ms9000001712287726, createdTime=Tue Apr 26 15:04:19 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210079, encodeId=e81b12100e9cc, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c66e8108716, createdName=ms5000000188518580, createdTime=Sun Apr 10 18:10:13 CST 2022, time=2022-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183213, encodeId=51d811832135f, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=09a95430606, createdName=花儿吃了那女孩, createdTime=Tue Jan 11 14:41:47 CST 2022, time=2022-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082949, encodeId=5ee71082949c5, content=。。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de6e5721166, createdName=滚蛋吧的肿瘤君, createdTime=Wed Dec 22 08:27:56 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077617, encodeId=ce0110e761775, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de6e5721166, createdName=滚蛋吧的肿瘤君, createdTime=Tue Dec 07 08:03:51 CST 2021, time=2021-12-07, status=1, ipAttribution=)]
    2021-12-22 滚蛋吧的肿瘤君

    。。

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1214557, encodeId=f516121455e75, content=***, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20ba8123961, createdName=ms9000001712287726, createdTime=Tue Apr 26 15:04:19 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210079, encodeId=e81b12100e9cc, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c66e8108716, createdName=ms5000000188518580, createdTime=Sun Apr 10 18:10:13 CST 2022, time=2022-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183213, encodeId=51d811832135f, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=09a95430606, createdName=花儿吃了那女孩, createdTime=Tue Jan 11 14:41:47 CST 2022, time=2022-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082949, encodeId=5ee71082949c5, content=。。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de6e5721166, createdName=滚蛋吧的肿瘤君, createdTime=Wed Dec 22 08:27:56 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077617, encodeId=ce0110e761775, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de6e5721166, createdName=滚蛋吧的肿瘤君, createdTime=Tue Dec 07 08:03:51 CST 2021, time=2021-12-07, status=1, ipAttribution=)]
    2021-12-07 滚蛋吧的肿瘤君

    积分

    0

以上为热门评论，梅斯医学App还有更多内容

相关指南

2022 GOLD慢性阻塞性肺疾病全球倡议：COPD诊断、治疗与预防全球策略

慢性阻塞性肺疾病全球倡议(GOLD,The Global Initiative for Chronic Obstructive Lung Disease) · 2021-11-15

慢阻肺的护理指南

暂未更新 · 2021-02-03

慢性阻塞性肺疾病诊治指南(2021年修订版)

中华医学会呼吸病学分会慢性阻塞性肺疾病学组 · 2021-03-04

慢性阻塞性肺疾病中医康复指南

世界中医药学会联合会 · 2020-12-15

2020 ATS临床实践指南：慢性稳定型高碳酸血症性慢性阻塞性肺疾病长期无创通气治疗

美国胸科学会(ATS,American Thoracic Society) · 2020-08-15

2020 ERS指南：慢性阻塞性肺疾病吸入性糖皮质激素停药

欧洲呼吸学会(ERS,European Respiratory Society) · 2020-05-04

拓展阅读

2013年慢性阻塞性肺疾病诊治指南（修订版）

中华医学会呼吸病学分会慢性阻塞性肺疾病学组 · 2013-04-01

2014 ACCP/CTS指南：预防慢性阻塞性肺疾病急性发作

美国胸科医师学会(ACCP,American College of Chest Physicians) · 2014-10-16

ICSI：2016慢性阻塞性肺疾病（COPD）的诊断和处理

临床系统改进协会(ICSI,Institute for Clinical Systems Improvement) · 2016-05-12

2013 慢性阻塞性肺疾病诊治指南（2013年修订版）

中华医学会呼吸病学分会慢性阻塞性肺疾病学组 · 2014-01-03

慢性阻塞性肺疾病诊断、处理和预防全球策略 (2017GOLD报告)解读

暂未更新 · 2017-01-11

2017 年GOLD慢性阻塞性肺疾病诊断、治疗及预防的全球策略解读

暂未更新 · 2017-01-30